Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Elevating EGFR-MAPK program by a nonconventional Cdc42 enhances intestinal epithelial survival and regeneration
Xiao Zhang, … , Ivaylo I. Ivanov, Nan Gao
Xiao Zhang, … , Ivaylo I. Ivanov, Nan Gao
Published July 20, 2020
Citation Information: JCI Insight. 2020;5(16):e135923. https://doi.org/10.1172/jci.insight.135923.
View: Text | PDF
Research Article Gastroenterology Stem cells

Elevating EGFR-MAPK program by a nonconventional Cdc42 enhances intestinal epithelial survival and regeneration

  • Text
  • PDF
Abstract

The regulatory mechanisms enabling the intestinal epithelium to maintain a high degree of regenerative capacity during mucosal injury remain unclear. Ex vivo survival and clonogenicity of intestinal stem cells (ISCs) strictly required growth response mediated by cell division control 42 (Cdc42) and Cdc42-deficient enteroids to undergo rapid apoptosis. Mechanistically, Cdc42 engaging with EGFR was required for EGF-stimulated, receptor-mediated endocytosis and sufficient to promote MAPK signaling. Proteomics and kinase analysis revealed that a physiologically, but nonconventionally, spliced Cdc42 variant 2 (V2) exhibited stronger MAPK-activating capability. Human CDC42-V2 is transcriptionally elevated in some colon tumor tissues. Accordingly, mice engineered to overexpress Cdc42-V2 in intestinal epithelium showed elevated MAPK signaling, enhanced regeneration, and reduced mucosal damage in response to irradiation. Overproducing Cdc42-V2 specifically in mouse ISCs enhanced intestinal regeneration following injury. Thus, the intrinsic Cdc42-MAPK program is required for intestinal epithelial regeneration, and elevating this signaling cascade is capable of initiating protection from genotoxic injury.

Authors

Xiao Zhang, Sheila Bandyopadhyay, Leandro Pires Araujo, Kevin Tong, Juan Flores, Daniel Laubitz, Yanlin Zhao, George Yap, Jingren Wang, Qingze Zou, Ronaldo Ferraris, Lanjing Zhang, Wenwei Hu, Edward M. Bonder, Pawel R. Kiela, Robert Coffey, Michael P. Verzi, Ivaylo I. Ivanov, Nan Gao

×

Figure 3

Cdc42 engages EGFR and endocytosis machinery.

Options: View larger image (or click on image) Download as PowerPoint
Cdc42 engages EGFR and endocytosis machinery.
(A) OptiPrep gradient cell...
(A) OptiPrep gradient cellular fractionation of HEK293 cells showed cosedimentation of Cdc42-V2 with EGFR, p-LRP6, and PI3K-P110 in lipid raft fractions marked Fyn, Cav1, and Flotillin. Calnexin is an ER marker. Data represent 3 independent experiments. (B) Coimmunoprecipitation analysis showed that Flag-tagged Cdc42 associated with full-length EGFR and EGFR intracellular domain (ICD) but not the extracellular domain (ECD) in HEK293 cells. (C) Coimmunoprecipitation analysis showed that, compared with V1, V2 exhibited a stronger interaction with endogenous EGFR and clathrin in HEK293 cells. (D) A diagram illustrating the structural and functional protein components found in Cdc42 proteomics that were known to regulate clathrin-mediated trafficking, EGFR endocytosis, and MAPK cascade.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts